
Biocon Limited has informed the Exchange regarding a press release dated November 30, 2023, titled "Biocon Biologics Successfully Completes Integration of Viatris Biosimilar Business in 31 Countries in Europe".
Filed with NSE ·

Biocon Limited has informed the Exchange regarding a press release dated November 30, 2023, titled "Biocon Biologics Successfully Completes Integration of Viatris Biosimilar Business in 31 Countries in Europe".
6ix hasn’t read this filing yet.
Follow Biocon into a list and get an email when it puts out news.
Follow Biocon